Edition:
United Kingdom

Neurotrope Inc (NTRP.OQ)

NTRP.OQ on NASDAQ Stock Exchange Capital Market

8.63USD
26 Apr 2018
Change (% chg)

$-0.07 (-0.80%)
Prev Close
$8.70
Open
$8.68
Day's High
$8.69
Day's Low
$8.63
Volume
443
Avg. Vol
8,990
52-wk High
$19.44
52-wk Low
$3.41

Chart for

About

Neurotrope, Inc., formerly BlueFlash Communications, Inc., is a biopharmaceutical company with its product candidates in pre-clinical and clinical development. The Company is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the... (more)

Overall

Beta: 2.86
Market Cap(Mil.): $68.87
Shares Outstanding(Mil.): 7.91
Dividend: --
Yield (%): --

Financials

  NTRP.OQ Industry Sector
P/E (TTM): -- 34.39 12.62
EPS (TTM): -1.65 -- --
ROI: -65.55 12.76 17.38
ROE: -65.55 15.32 18.47

BRIEF-Neurotrope's Bryostatin Improves Cognition In Patients

* NEUROTROPE'S BRYOSTATIN IMPROVES COGNITION IN PATIENTS WITH ADVANCED ALZHEIMER'S DISEASE BASED ON FURTHER ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA Source text for Eikon: Further company coverage:

05 Jan 2018

BRIEF-Neurotrope Appoints Charles S. Ryan As CEO

* NEUROTROPE APPOINTS CHARLES S. RYAN AS CHIEF EXECUTIVE OFFICER

18 Dec 2017

Earnings vs. Estimates